Cargando…

Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using (18)F-FET PET

Molecular markers are of increasing importance for classifying, treating, and determining the prognosis for central nervous system tumors. Isocitrate dehydrogenase (IDH) is a critical regulator of glucose and amino acid metabolism. Our objective was to investigate metabolic reprogramming of glioma u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lohmeier, Johannes, Radbruch, Helena, Brenner, Winfried, Hamm, Bernd, Tietze, Anna, Makowski, Marcus R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2023
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626372/ https://www.ncbi.nlm.nih.gov/pubmed/37652542 http://dx.doi.org/10.2967/jnumed.123.265642

Ejemplares similares

Quantitative biparametric analysis of hybrid (18)F-FET PET/MR-neuroimaging for differentiation between treatment response and recurrent glioma
por: Lohmeier, Johannes, et al.
Publicado: (2019)

Author Correction: Quantitative biparametric analysis of hybrid (18)F-FET PET/MR-neuroimaging for differentiation between treatment response and recurrent glioma
por: Lohmeier, Johannes, et al.
Publicado: (2020)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

(18)F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Prediction of Glioma Grade and IDH Status Using (18)F-FET PET/CT Dynamic and Multiparametric Texture Analysis
por: Hajri, Rami, et al.
Publicado: (2023)

Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
por: Rosen, Jurij, et al.
Publicado: (2021)

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers
por: Skoblar Vidmar, Marija, et al.
Publicado: (2022)

Lesion-to-background ratio threshold value of SUVmax of simultaneous [(68)Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
por: Zhao, Jing, et al.
Publicado: (2020)

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [(18)F]FET PET radiomics
por: Li, Zhicong, et al.
Publicado: (2021)

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
por: Gutsche, Robin, et al.
Publicado: (2021)

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
por: Neumaier, Felix, et al.
Publicado: (2023)

Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [(68)Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1
por: Zhao, Jing, et al.
Publicado: (2020)

Early [(18)F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and Histopathology
por: Kläsner, Benjamin, et al.
Publicado: (2015)

DDRE-12. HETEROGENOUS RESPONSE OF IDH-MUTANT AND IDH-WT GLIOMA TO NAMPT INHIBITION
por: Rahman, Masum, et al.
Publicado: (2021)

Voxel-based (18)F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas
por: Blanc-Durand, Paul, et al.
Publicado: (2018)

PREOPERATIVE DETERMINATION OF IDH STATUS AND GRADE IN GLIOMAS USING MRS
por: Nguyen, Thanh Binh
Publicado: (2023)

atlasBREX: Automated template-derived brain extraction in animal MRI
por: Lohmeier, Johannes, et al.
Publicado: (2019)

Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to(68)Ga-PSMA PET-CT
por: Meißner, Sebastian, et al.
Publicado: (2019)

METABOLOGENOMIC CHARACTERIZATION UNCOVERS HETEROGENEITY AMONG IDH MUTANT GLIOMAS
por: Ajisebutu, Andrew, et al.
Publicado: (2023)

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
por: Müller, Marguerite, et al.
Publicado: (2022)

Dynamic Contrast-Enhanced MRI of Prostate Lesions of Simultaneous [(68)Ga]Ga-PSMA-11 PET/MRI: Comparison between Intraprostatic Lesions and Correlation between Perfusion Parameters
por: Zhao, Jing, et al.
Publicado: (2021)

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
por: Wollring, Michael M., et al.
Publicado: (2022)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

Fibrin-targeting molecular MRI in inflammatory CNS disorders
por: Lohmeier, Johannes, et al.
Publicado: (2022)

Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with (68)Ga-PSMA-HBED-CC PET-positive prostate cancer lesions
por: Meißner, Sebastian, et al.
Publicado: (2017)

Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features
por: Puranik, Ameya D., et al.
Publicado: (2019)

Combination of pre-treatment dynamic [(18)F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
por: Li, Zhicong, et al.
Publicado: (2022)

Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo (1)H-Magnetic Resonance Spectroscopy and Machine Learning
por: Bumes, Elisabeth, et al.
Publicado: (2020)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
por: Chang, Yu-Zhou, et al.
Publicado: (2020)

The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET
por: Malkowski, Bogdan, et al.
Publicado: (2015)

Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
por: Galldiks, Norbert, et al.
Publicado: (2019)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

Multiparametric Characterization of Intracranial Gliomas Using Dynamic [18F]FET-PET and Magnetic Resonance Spectroscopy
por: Pyka, Thomas, et al.
Publicado: (2022)

[(18)F]FET PET Uptake Indicates High Tumor and Low Necrosis Content in Brain Metastasis
por: Meyer, Hanno S., et al.
Publicado: (2021)

Imaging coronary plaques using 3D motion-compensated [(18)F]NaF PET/MR
por: Mayer, Johannes, et al.
Publicado: (2021)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET
por: Liu, Feng-Min, et al.
Publicado: (2021)

Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
por: Tatekawa, Hiroyuki, et al.
Publicado: (2021)

Prognostic value of (18)F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma
por: Dissaux, Gurvan, et al.
Publicado: (2020)

Glioma Biopsy Based on Hybrid Dual Time-Point FET-PET/MRI—A Proof of Concept Study
por: Furtak, Jacek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n4eu4tehivvvq5oq9crc4dnf8h